Sands Capital Alternatives, LLC
Position in TSHA — Taysha Gene Therapies, Inc.
CIK 1846444
ARLINGTON, VA
Position in TSHA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,936,385
+$1,696,203 QoQ
Shares Held
724,873
0.0% QoQ
Ownership
0.222%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#45
of 208 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TSHA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sands Capital Alternatives, LLC holds $126,924,003 across 8 Biotechnology names. TSHA ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SGP |
SpyGlass Pharma, Inc.
|
2,500,012 | $55,650,267 | |
| 2 | IKT |
Inhibikase Therapeutics, Inc.
|
13,018,965 | $26,428,498 | |
| 3 | ODTX |
Odyssey Therapeutics, Inc.
|
875,000 | $16,371,250 | |
| 4 | ABOS |
Acumen Pharmaceuticals, Inc.
|
3,720,105 | $9,932,680 | |
| 5 | TARS |
Tarsus Pharmaceuticals, Inc.
|
85,000 | $5,349,900 | |
| 6 | TSHA |
Taysha Gene Therapies, Inc.
This page
|
724,873 | $4,936,385 | |
| 7 | CADL |
Candel Therapeutics, Inc.
|
405,837 | $4,180,121 | |
| 8 | ACRV |
Acrivon Therapeutics, Inc.
|
2,289,271 | $4,074,902 |
All Filings in TSHA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,936,385 | 724,873 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,240,182 | 724,873 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $3,986,801 | 724,873 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,370,334 | 724,873 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,674,456 | 724,873 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,007,573 | 724,873 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,254,030 | 724,873 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,456,994 | 724,873 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,623,715 | 724,873 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,080,385 | 724,873 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,283,025 | 724,873 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,290,598 | 724,873 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $479,141 | 724,873 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $578,448 | 724,873 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,638,212 | 724,873 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,399,004 | 724,873 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,696,527 | 724,873 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,726,171 | 724,873 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $8,444,770 | 724,873 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $13,497,135 | 724,873 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||